Literature DB >> 19799858

Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.

Gregory V Nikiforovich1, Thomas J Baranski.   

Abstract

The study presents structural models for the complex of the chemotaxis inhibitory protein of Staphylococcus aureus, CHIPS, and receptor for anaphylotoxin C5a, C5aR. The models are based on the recently found NMR structure of the complex between CHIPS fragment 31-121 and C5aR fragment 7-28, as well as on previous results of molecular modeling of C5aR. Simple and straightforward modeling procedure selected low-energy conformations of the C5aR fragment 8-41 that simultaneously fit the NMR structure of the C5aR 10-18 fragment and properly orient the NMR structure of CHIPS(31-121) relative to C5aR. Extensive repacking of the side chains of CHIPS(31-121) and C5aR(8-41) predicted specific residue-residue interactions on the interface between CHIPS and C5aR. Many of these interactions were rationalized with experimental data obtained by site-directed mutagenesis of CHIPS and C5aR. The models correctly showed that CHIPS binds only to the first binding site of C5a to C5aR not competing with C5a fragment 59-74, which binds the second binding site of C5aR. The models also predict that two elements of CHIPS, fragments 48-58 and 97-111, may be used as structural templates for potential inhibitors of C5a.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799858      PMCID: PMC2787753          DOI: 10.1016/j.bbrc.2009.09.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.

Authors:  G V Nikiforovich; B Mihalik; K J Catt; G R Marshall
Journal:  J Pept Res       Date:  2005-11

3.  The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.

Authors:  Pieter-Jan Haas; Carla J C de Haas; Miriam J J C Poppelier; Kok P M van Kessel; Jos A G van Strijp; Klaas Dijkstra; Ruud M Scheek; Hao Fan; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
Journal:  J Mol Biol       Date:  2005-09-23       Impact factor: 5.469

4.  N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.

Authors:  Pieter-Jan Haas; Carla J C de Haas; Wendy Kleibeuker; Miriam J J G Poppelier; Kok P M van Kessel; John A W Kruijtzer; Rob M J Liskamp; Jos A G van Strijp
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.

Authors:  J A DeMartino; G Van Riper; S J Siciliano; C J Molineaux; Z D Konteatis; H Rosen; M S Springer
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

6.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Topographical requirements for delta-selective opioid peptides.

Authors:  G V Nikiforovich; V J Hruby; O Prakash; C A Gehrig
Journal:  Biopolymers       Date:  1991-07       Impact factor: 2.505

8.  Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.

Authors:  Bent Postma; Miriam J Poppelier; Joost C van Galen; Eric R Prossnitz; Jos A G van Strijp; Carla J C de Haas; Kok P M van Kessel
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

9.  Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.

Authors:  Andrew J Wright; Adrian Higginbottom; Didier Philippe; Abhishek Upadhyay; Stefan Bagby; Robert C Read; Peter N Monk; Lynda J Partridge
Journal:  Mol Immunol       Date:  2007-01-26       Impact factor: 4.407

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  4 in total

1.  Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.

Authors:  Gregory V Nikiforovich; Garland R Marshall; Thomas J Baranski
Journal:  Proteins       Date:  2010-11-30

Review 2.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

3.  Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Zhen-jia Liu; Yan-juan Yang; Lei Jiang; Ying-chun Xu; Ai-xia Wang; Guan-hua Du; Jin-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

Review 4.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.